CHICAGO, Aug. 2, 2018 /PRNewswire-PRWeb/ -- Founded in 2016, family-owned GENIAL DAY INC. (https://genialday.com/)
Today in the US, they are encouraging women to #DetoxYourPeriod.
In March 2017, 16 year old Sara Manitoski was found dead on an overnight school trip near Vancouver Island. It was determined that her death was caused by the rare, but often deadly, toxic shock syndrome, related to her tampon use. (https://www.newsweek.com/what-toxic-shock-syndrome-teen-girl-dies-school-trip-1000833) The strain of bacteria known as staphylococcus aureus, found on the tampon that was in her body, was lethal to this otherwise healthy, vibrant teen.
Dr. JoAnn Pinkterton, executive director of The North American Menopause Society stated that, "Younger women are more likely to get TSS, possibly because of more exposure through tampons or barrier contraceptive use." She also stated that, "It may also be because they haven't developed the antibodies yet."
What's even more concerning are the chemicals next to your skin that are absorbed straight into your bloodstream. According to physicial and writer, Dr. Joseph Mercola (https://www.mercola.com/) It's worse than eating them! Chemicals in pads and tampons like BPA and BPS disrupt embryonic development and are linked to heart disease and cancer. Phthalates deregulate gene expression, and DEHP may lead to multiple organ damage. It's that bad.
But detoxing and making eco-friendly choices for your period and undergarments could literally save your life and Genial Day does just that!
In addition to the obvious health benefits, check out this amazing video: Absorption Challenge (https://www.youtube.com/watch?v=RWaS7yt0tRA) comparing Genial Day with other leading brands. Get ready to be shocked: Yes, Genial Day pads hold up to 400X it's weight yet stay safe and non-toxic. Win/win!
SOURCE Genial Day
Subscribe to our Free Newsletters!
Collagen plays a crucial role in glowing skin, strong nails and shiny hair. You can boost collagen ...
CRISPR technology is a simple but potent tool for editing any part of the genome (complete set of ...
FDA recently approved Mogamulizumab-kpkc, a human monoclonal antibody prescribed for adult ...View All